These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1616225)

  • 1. Subcutaneous compared with intravenous heparin for deep vein thrombosis.
    Moser KM; Fedullo PF
    Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616225
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.
    Doyle DJ; Turpie AG; Hirsh J; Best C; Kinch D; Levine MN; Gent M
    Ann Intern Med; 1987 Oct; 107(4):441-5. PubMed ID: 3307582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous or intravenous heparin for deep vein thrombosis.
    Bounameaux H; Krahenbuhl B
    Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1690-1. PubMed ID: 3113593
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs.
    Scolding N
    Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1551-2. PubMed ID: 3111633
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous compared with intravenous heparin for deep vein thrombosis.
    Burnum JF
    Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616224
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study.
    Robinson AM; McLean KA; Greaves M; Channer KS
    Postgrad Med J; 1993 Feb; 69(808):115-6. PubMed ID: 8506190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous compared with intravenous heparin for deep vein thrombosis.
    Young MA
    Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616226
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Pineo GF; Green D; Trowbridge AA; Elliott CG; Lerner RG; Hall J; Sparling T; Brettell HR
    N Engl J Med; 1992 Apr; 326(15):975-82. PubMed ID: 1545850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
    Teo CP; Lim HL; Kueh YK
    Thromb Haemost; 1994 Aug; 72(2):328-9. PubMed ID: 7831676
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis.
    Lockner D; Bratt G; Törnebohm E; Aberg W; Granqvist S
    Haemostasis; 1986; 16 Suppl 2():25-9. PubMed ID: 3744133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis.
    Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Nilsson E; Wilhelmsson S; Zetterquist S
    Thromb Res; 1982 Sep; 27(6):631-9. PubMed ID: 7179208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of deep venous thrombosis with fixed doses of subcutaneous heparin. Preliminary results].
    Lastória S; Maffei FH; Rollo HA; Yoshida WB; Castiglia V; Lorenzi LC; Lintz JA; Sanchez MA
    AMB Rev Assoc Med Bras; 1983; 29(11-12):188-90. PubMed ID: 6608754
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of an algorithm for administering subcutaneous heparin in the treatment of deep venous thrombosis.
    Prandoni P; Bagatella P; Bernardi E; Girolami B; Rossi L; Scarano L; Marchiori A; Piccioli A; Girolami A
    Ann Intern Med; 1998 Aug; 129(4):299-302. PubMed ID: 9729183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of venous thrombosis with subcutaneous heparin.
    Salzman EW
    N Engl J Med; 1982 Jan; 306(4):232-4. PubMed ID: 7054685
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of iliofemoral thrombosis in a pregnant patient with heparin resistance.
    Anand SS; Brimble S; Ginsberg JS
    Arch Intern Med; 1997 Apr; 157(7):815-6. PubMed ID: 9125015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis.
    Hommes DW; Bura A; Mazzolai L; Büller HR; ten Cate JW
    Ann Intern Med; 1992 Feb; 116(4):279-84. PubMed ID: 1531108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.